Dr Reddy’s Takes Another Step Forward On Tocilizumab

IV Version Of Indian Firm’s Actemra/RoActemra Biosimilar Completes Phase I Study

 
• By David Wallace
Clinical Trial Icon
Dr Reddy’s has completed another trial for its tocilizumab candidate • Source: Shutterstock

More from Biosimilars

More from Products